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Mesenchymal stem and progenitor cells (MSPCs)
contribute to bone marrow (BM) homeostasis by
generating multiple types of stromal cells. MSPCs
can be labeled in the adult BM by Nestin-GFP,
whereas committed osteoblast progenitors are
marked by Osterix expression. However, the devel-
opmental origin and hierarchical relationship of stro-
mal cells remain largely unknown. Here, by using a
lineage-tracing system, we describe three distinct
waves of contributions of Osterix+ cells in the BM.
First, Osterix+ progenitors in the fetal BM contribute
to nascent bone tissues and transient stromal cells
that are replaced in the adult marrow. Second,
Osterix-expressing cells perinatally contribute to
osteolineages and long-lived BM stroma, which
have characteristics of Nestin-GFP+ MSPCs. Third,
Osterix labeling in the adult marrow is osteoline-
age-restricted, devoid of stromal contribution. These
results uncover a broad expression profile of Osterix
and raise the intriguing possibility that distinct waves
of stromal cells, primitive and definitive, may orga-
nize the developing BM.
INTRODUCTION
The bone marrow (BM) environment is composed of multiple cell
types, most of which are thought to be derived from mesen-
chymal stem and progenitor cells (MSPCs) (Bianco et al., 2013;
Caplan, 1991; Frenette et al., 2013). Stromal progenitor activity
in the BM was initially isolated from clonal populations of fibro-
blastic colony-forming units (CFU-F) that exhibit self-renewal
and the capacity to differentiate into the major mesenchymal
lineages (Friedenstein et al., 1968; Me´ndez-Ferrer et al., 2010;
Sacchetti et al., 2007). Although surface markers have been sug-340 Developmental Cell 29, 340–349, May 12, 2014 ª2014 Elsevier Ingested to mark MSPCs (Dominici et al., 2006), these were based
on cultured stromal cells, but not on prospectively isolated native
stroma and lack specificity to identify native bone marrow
MSPCs (Bianco et al., 2013). In the mouse BM, transgenic
mice expressing GFP under the Nestin promoter (Nes-GFP)
select for MSPC activity and so do stromal cells with CD45
Tie2 CD90 CD51+ CD105+ phenotype (Chan et al., 2009),
CXCL12 abundant reticular (CAR) cells (Omatsu et al., 2010),
PDGFRa+ Sca-1+ (Morikawa et al., 2009), CD51+ PDGFRa+
(Pinho et al., 2013), and Prx-1-derived CD45 Ter119PDGFRa+
Sca-1+ populations (Greenbaum et al., 2013). There is evidence
that these stromal cell populations display some significant over-
lap with each other and comprise important cellular constituents
of the hematopoietic stem cell (HSC) niche. For example, Nes-
GFP+ cells highly overlap with leptin receptor (Lepr)-expressing
perivascular cells (Pinho et al., 2013), which were shown to be
a major source of CXCL12 and stem cell factor (SCF) in the
BM (Ding and Morrison, 2013; Ding et al., 2012). These reports
thus suggest that MSPCs organize the BM environment by
contributing to osteolineage cells and regulating HSC self-
renewal and differentiation.
Additionally, other studies have suggested a role for osteo-
blasts as a constituent of the HSC niche. Gain- and loss-of func-
tion approaches have shown that alterations in osteoblast
numbers correlate with the number of HSCs (Calvi et al., 2003;
Visnjic et al., 2004; Zhang et al., 2003), although the correlation
was not observed in other models (Kiel et al., 2007; Lymperi
et al., 2008). Osteoblasts have been suggested to regulate the
HSCs via secretion of angiopoietin-1 (Arai et al., 2004), osteo-
pontin (Nilsson et al., 2005; Stier et al., 2005), and noncanonical
Wnt signaling (Sugimura et al., 2012). However, the expression
of these factors is not specific to osteoblasts and there is no
evidence thus far that specific deletion of these factors in
committed osteoblasts affects HSC maintenance.
One of the promoters expressed in the bone marrow thought
to be specific to the osteolineage is Osterix (Osx), a transcription
factor shown to be required for bone formation (Nakashima et al.,
2002). During bone development, Osx+ osteoblast precursors
appear around the perichondrium and subsequently migratec.
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vessels, giving rise to mature osteolineage cells (Karsenty and
Wagner, 2002; Maes et al., 2010). In the adult, Osx+ cells provide
a transient source of osteoblasts (Park et al., 2012), implying the
presence of a more primitive source sustaining osteolineage
cells throughout the lifetime. Here, we show unexpectedly that
Osx marks successive waves of progenitors during ontogeny,
including bona fide MSPCs at the perinatal stage. In addition,
our studies have uncovered temporally distinct stromal precur-
sors, termed primitive and definitive stroma, that differentially
contribute to skeletal development.
RESULTS AND DISCUSSION
Neonatal Osx+ Cells Give Rise to Long-Lived BMStromal
Cells
To trace lineages of Osx-expressing cells in the developing
bone and BM, we generated double-transgenic Osx-creERT2/
ROSA26-loxP-stop-loxP-tdTomato (iOsx/Tomato) reporter mice
where cre expression in Osx+ cells can be induced at different
developmental stages by administration of tamoxifen (Tam).
Consistent with previous observations (Maes et al., 2010), Osx+
cells were labeled in the perichondrium 1 day after Tam injection
in embryonic day 13.5 (E13.5) mice, before the formation of a
BM cavity (Figure 1A). The iOsx expression was consistent with
staining of the endogenous protein using an anti-Osx antibody
confirming the specificity of transgenic expression (Figure S1A
available online). After a chase of 2 weeks, Osx+ cell progeny
(designated E13.5-iOsx/Tomato+ cells) were detected in the
primary spongiosa adjacent to blood vessels (Figure 1B1) labeled
by VE-cadherin and PECAM-1 staining and around the cortical
bone (Figure 1B2). Osx+ cells labeled during fetal BM develop-
ment gave rise to the full spectrum of osteolineage cells in the
growing bone (Maes et al., 2010). Interestingly, our results re-
vealed that 2 weeks after labeling, E13.5-iOsx/Tomato+ cells
were not only detected in bone tissues, but also in stromal cells
that did not express osteocalcin, in contact with the vasculature
(Figures 1B2 and S1C). However, following a chase of 13 weeks,
the osteolineage and BM stromal cells were dramatically
decreased, along with the longitudinal growth, suggesting that
embryonic Osx+ progenitor cells transiently contribute to the
developing bone and marrow stroma (Figures 1C and S1D).
We then marked Osx+ cells at postnatal day 5 (PND5; desig-
nated P5-iOsx/Tomato+ cells) and found that they included cells
of the primary spongiosa and around the cortical bone, but not in
the BM cavity 1 day after Tam injection (Figure 1D). The speci-
ficity of the iOsx-marked cells was also confirmed at this time
point using anti-Osx antibody staining (Figure S1B). FACS anal-
ysis revealed that P5-iOsx/Tomato+ cells in the bone tissue were
CD45 Ter119 CD31 stromal cells (97.6% ± 0.4%) and that
these cells were rarely detected in the BM 1 day after Tam injec-
tion (Figure S1E). However, after a chase of 3 weeks, P5-iOsx/
Tomato+ osteoblasts and osteocytes were detected around
the bone and, unexpectedly, P5-iOsx/Tomato+ stromal cells
were also observed adjacent to blood vessels in the BM cavity
(Figure 1E). In addition, the stromal cell labeling persisted for at
least 32weeks throughout the BM (Figure 1F: chase of 24weeks;
Figure S1F: chase of 32 weeks). FACS analysis of P5-iOsx/
Tomato+ cells after a chase of 15 weeks indicated that theyDeveremained confined to the stromal CD45 Ter119 CD31
compartment (97.7% ± 0.4%; Figure S1G). Further analyses of
the characteristics of the P5-iOsx/Tomato+ BM cells revealed
that the cells became quiescent during bone growth (Figures
S1H and S1I). The contribution of P5-iOsx/Tomato+ cells to the
BM stroma increased in a time-dependent manner as seen by
the progressive increased frequencywithin total stroma and their
absolute number per femur (Figures S2A and S2B). By contrast,
iOsx/Tomato mice pulsed in the adult stage (8 weeks of age) dis-
played restricted labeling to the bone tissues 1 day post-Tam in-
jection (Figure 1G) and did not generate BM stromal cells after
2 or 7 weeks chase (Figures 1H and 1I). Consistent with recent
studies (Park et al., 2012), iOsx labeling was reduced after
7 weeks (Figures 1G–1I), suggesting that iOsx marks nonself-
renewing osteoprogenitors in the 8 weeks pulsed iOsx/Tomato
mice. Indeed, after a chase of 12–15weeks, a significantly higher
number of iOsx/Tomato+ bone-lining cells was found in the P5
pulsed mouse bone tissue than in the 8-week-old pulsed mice
(Figures S2C–S2E; 38.6% ± 6.5% versus 8.0% ± 1.4%, p <
0.05), and these cells were sustained for up to 32 weeks (Fig-
ure S1F), suggesting that the P5-iOsx/Tomato+ cells contain
long-lived stromal cells that contribute to osteolineages. These
stromal cells can self-renew in vitro because clonally expanded
P5-iOsx/Tomato+ cells were able to form primary spheres in non-
adherent culture conditions (Me´ndez-Ferrer et al., 2010) and
when dissociated, could form secondary clonal spheres with a
similar efficiency as the primary spheres (primary: 0.6% ±
0.1%; secondary: 0.5% ± 0.1%; Figures S2F and S2G). These
results thus suggest that iOsx temporally marks at least three
distinct mesenchymal precursor cells in the fetal, perinatal, and
adult bone marrow and that the perinatal Osx-expressing cells,
which become quiescent during bone growth, also exhibit self-
renewal capacity.
P5-iOsx-Derived BM Stromal Cells Possess MSPC
Characteristics
To test whether P5-iOsx/Tomato+ stromal cells containedMSPC
activity, we generated Nes-Gfp/iOsx/Tomato triple-transgenic
mice. One day after Tam injection, a fraction of P5-iOsx/Tomato+
cells in the primary spongiosa and around the cortical bone area
were Nes-GFP+ (Figure 2A). FACS analysis showed that 38.2%±
2.2% of P5-iOsx/Tomato+ cells in the bone tissue expressed
Nes-GFP (Figure 2C). However, most (84.9% ± 6.5%) of P5-
iOsx/Tomato+ BM cells were Nes-GFP+ by histological and
FACS analyses 15 weeks after Tam injection (Figures 2B and
2D). P5-iOsx/Tomato+ BM stromal cells were highly enriched in
CFU-F activity (Figure 2E) whose colonies exhibited Tomato
fluorescence (Figure 2F), thereby confirming that they were
derived from Osx+ cells marked at P5. Furthermore, the clonally
expanded P5-iOsx/Tomato+ BM cells exhibited trilineage differ-
entiation potential (Figures 2G–2I). The persistence of perinatally
marked iOsx stromal cells in the bone marrow is consistent with
recently published data in which E14.5 Osx-expressing cells
marked long-lived stroma (Liu et al., 2013). Thus, definitive
MSPCs may be established late in gestation.
Recent studies reported that leptin receptor+ (Lepr)+ stromal
cells contribute to HSC maintenance as a major source of SCF
(Ding et al., 2012). Our recent analyses indicate that Lepr+ cells
in the BM largely overlap with Nes-GFP+ cells (Pinho et al.,lopmental Cell 29, 340–349, May 12, 2014 ª2014 Elsevier Inc. 341
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Figure 1. Lifelong Contribution of Osx+ Cells to the BM Cells in Developing Bones
Z stack confocal images of thick bone sections of iOsx/Tomato mice administered with tamoxifen (Tam) at embryonic day 13.5 (E13.5) (A–C), postnatal day 5 (P5)
(D–F), and 8-week-old (G–I) mice analyzed at the indicated periods. Bone sections were stained with VE-cadherin (VE-Cad), PECAM-1 antibodies (green), and
Hoechst 33342 (blue). Right panels are magnified views of the boxed areas. Scale bars represent 100 mm. Arrows: iOsx-derived Tomato+ (iOsx/Tomato+) stromal
cells. Arrowheads: iOsx/Tomato+ osteolineage cells. See also Figures S1 and S2.
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Figure 2. Osx+ Cells in the Neonatal Bone Give Rise to Nes-GFP+ MSPCs
Analysis of Nes-Gfp/iOsx/Tomato mice administered with tamoxifen (Tam) at P5.
(A and B) Z stack confocal images of thick bone sections at 1 day (A) and 15weeks (B) after Tam injection. Bone sections were stained with VE-cadherin (VE-Cad)
and PECAM-1 antibodies (white). Right panels are magnified confocal images within the area defined by the rectangle. Arrows: Nes-GFP and iOsx-derived
Tomato (iOsx/Tomato) double-positive cells.
(legend continued on next page)
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Lepr in P5-iOsx/Tomato+ BM cells with an anti-Lepr antibody.
We found that most P5-iOsx/Tomato and Nes-GFP double-
positive cells at 15 weeks after Tam injection expressed Lepr
by immunostaining (Figure 2J) and flow cytometry (Figure 2K;
78% ± 4.5%), and this population also expressed the MSPC
markers PDGFRa (89%) and PDGFRb (83%) (Figure 2K) (Cri-
san et al., 2008; Morikawa et al., 2009; Pinho et al., 2013). On the
other hand, the expression of Lepr was very low in P5-iOsx/
Tomato+ cells at 1 day after Tam injection (Figure S2H), suggest-
ing that the Lepr expression increases in the P5-iOsx/Tomato+
BM cells during bone maturation. Interestingly, E13.5-iOsx/
Tomato+ BM cells also express Nes-GFP, Lepr, PDGFRa, and
PDGFRb after a chase of 2 weeks (Figures S2I and S2J). Ono
et al. (2014) suggest that some of the Osx+ cells labeled at
E12.5 overlap with Nes-GFP+ cells. Collectively, these results
thus support the idea that Osx+ cells in the neonatal bone
marrow are the precursors of Nes-GFP+ Lepr+ MSPCs in the
adult BM, although whether Osx+ cells were initially Nes-GFP+
cannot be excluded.
Lepr-cre-Derived BM Stromal Cells Contribute to the
Osteolineage in Adulthood
Lepr-marked stromal cells were suggested to be restricted to
perivascular areas and do not contribute to osteolineage cells
(Ding et al., 2012). Because we found that Lepr was expressed
in Nes-GFP+MSPCs, we analyzed the contribution of Lepr+ cells
to bone tissues in Nes-Gfp/Lepr-cre/Tomato triple transgenic
mice. Consistent with the above antibody staining experiments
(Figures 2J and 2K), Lepr-cre-derived Tomato+ cells (hereafter
Lepr/Tomato+) expressed Nes-GFP, PDGFRa, and PDGFRb
(Figure S3A). Furthermore, clonally expanded Lepr/Tomato+
cells exhibited trilineage differentiation capacity (Figures S3B–
S3D), indicating that these populations highly overlap with the
P5-iOsx/Tomato+ cells in the BM. During early limb develop-
ment, Lepr/Tomato+ cells were not present in the primary ossifi-
cation center at E15.5, whereas Nes-GFP+ and Osx+ cells were
expressed at this time in this location (Figure 3A). Lepr/Tomato+
cells were first detected in the primary spongiosa and in the peri-
osteum of the bone tissue at E17.5 and subsequently were pre-
sent throughout the BM cavity in 1-week-old mice (Figure 3A).
Immunofluorescence analyses revealed that Lepr/Tomato+ cells
were positive for Nes-GFP and Osx in the primary spongiosa in
1-week-old mice (Figure S3E). By FACS analysis, most (92%)(C and D) Representative FACS plots showing the percentages of the Nes-GFP+ c
(n = 3) and in the BM (D) (n = 3) after 1 day and 15 weeks of chase, respectively. Bl
represented as mean ± SEM.
(E and F) CFU-F activity of sorted iOsx/Tomato+ and iOsx/Tomato populations i
representative image of CFU-F colony (F; Giemsa staining on the left panel and Tom
(E) Data are represented as mean ± SEM.
(G–I) Differentiated phenotypes of clonal iOsx/Tomato+ BM stromal cells show
antibody: adipocytes (H), and Alcian Blue: chondrocytes (I). Nuclei were detecte
(J) Confocal images of Nes-GFP and iOsx/Tomato double-positive BM stromal c
iOsx/Tomato, and Lepr triple-positive cells.
(K) Representative FACS plots showing the percentages of Nes-GFP and Lepr d
Tomato+ (CD45Ter119CD31) BM stromal population in 15-week-old mice. Bl
indicated, respectively. n = 3. Data are represented as mean ± SEM.
Scale bars represent 5,000 mm (G), 500 mm (F, left panel) and (I), 200 mm (A, left pan
panel), (H), and (J). See also Figure S2.
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GFP at 1 week of age (Figure S3F).
Next, we analyzed bone tissues of 3- and 15-week-old Lepr-
cre/Tomato mice to investigate the osteolineage contribution
of Lepr/Tomato+ BM stromal cells. In 3-week-old animals,
Lepr/Tomato+ cells were distributed throughout the BM cavity,
but were not present along the endosteum (Figure 3B, left). By
contrast, in the 15-week-old bone tissues, Lepr/Tomato+ cells
were observed not only in the BM cavity, but also along the
cortical bone (Figure 3B, right). Immunofluorescence staining
showed that Lepr/Tomato+ cells in the bone tissue were osteo-
calcin- and dentin matrix protein 1 (DMP1)-expressing mature
osteoblasts and osteocytes, respectively (Figures 3C and 3D).
Lepr/Tomato+ osteolineage cells were also observed in the
trabecular bone of 15-week-old mice (Figure S3G). To examine
whether Lepr/Tomato+ mature osteolineage cells express Lepr,
we performed immunofluorescence staining with anti-Lepr anti-
body in Col1(2.3)-Gfp and Lepr-cre/Tomato mice. We found that
Col1(2.3)-GFP+ mature osteoblasts and Lepr/Tomato+ osteoli-
neage cells were negative for Lepr (Figures 3E and 3F). In addi-
tion, Lepr mRNA was not detectable by quantitative real-time
PCR in the osteoblasts (Figures S3H–S3J). These results sug-
gest that Lepr/Tomato+ mature osteolineage cells do not auton-
omously express Lepr, but are descendant of Lepr+ precursors.
Further, these data indicate that BM cells marked by Lepr-cre
highly overlap with P5-iOsx/Tomato+ BM stromal cells that are
a permanent source of osteoprogenitors contributing to adult
bone homeostasis.
P5-iOsx-Derived BM Stromal Cells Contribute to Tissue
Regeneration after Injury
Although MSPCs are thought to have the potential to differen-
tiate into osteoblasts and adipocytes (Takada et al., 2009), their
contribution to these lineages in vivo remains unclear. To test
whether Lepr/Tomato+ and P5-iOsx/Tomato+ BM stromal cells
had the potential to generate adipocytes in vivo, we challenged
8-week-old Lepr-cre/Tomato and 15-week-old iOsx/Tomato
mice pulsed at P5 with 6 Gy irradiation, an injury known to
induce fatty infiltration in the BM (Bryon et al., 1979). Adipocytes,
identified by staining with BODIPY (493/503), a dye that stains
lipid droplets (Spangenburg et al., 2011) and perilipin, an
essential protein for adipogenesis (Martinez-Botas et al., 2000)
were dramatically increased in the BM 6 days after irradiation
(Figures 4A–4F and S4A). Importantly, these adipocytes wereells within the iOsx/Tomato+ (CD45Ter119CD31) population in the bone (C)
ue and red lines represent the WT control and Nes-GFP, respectively. Data are
n the BM stroma harvested 4 weeks after Tam injection. Quantification (E) and
ato fluorescence on the right panel). n = 3 independent experiments. *p < 0.05.
n by Alizarin Red S: osteoblasts (G), lipid droplets and staining with FABP4
d by DAPI (blue).
ells stained with Lepr antibody in 15-week-old mice (white). Arrows: Nes-GFP,
ouble-positive cells and the expression of PDGFRa and PDGFRb in the iOsx/
ue and red lines represent isotype controls and antibodies against the markers
el) and (B, left panel), 100 mm (F, right panel), and 30 mm (A, right panel), (B, right
c.
Lepr-cre/
Tomato
Osx
Nestin
Lepr-cre/
Tomato
Osx
Nestin
E15.5A E17.5
BoneBone
3 weeks 15 weeksB
Lepr-cre/
Tomato
Hoechst
Lepr-cre/
Tomato 
Hoechst
Lepr-cre/
Tomato
Osx
Nestin
1 week
Lepr-cre/
Tomato
Hoechst
DMP1
Hoechst Merged
D
Bone Bone Bone
Lepr-cre/
Tomato
Hoechst
Osteocalcin
Hoechst
MergedC
Bone
Bone
Lepr
Col1(2.3)-GFP
Hoechst
Lepr
Hoechst
Lepr-cre/Tomato Lepr Hoechst
Lepr Hoechst
Bone
Bone
E F
Lepr Col1(2.3)-GFP 
Hoechst
Figure 3. Lepr-cre-Derived BM Stromal Cells Give Rise to Bone-Lineages in the Adult Stage
(A) Z stack confocal images of thick bone sections of Nes-Gfp/Lepr-cre/Tomato mice in the indicated stages, stained with Osx antibody (white). *Primary
ossification center. Arrows: Lepr-cre-derived Tomato+ (Lepr/Tomato+) cells in the epiphysis. Arrowheads: Lepr/Tomato+ cells in the periosteum.
(B) Z stack confocal images of thick bone sections of Lepr-cre/Tomato mice in the indicated stages. Arrows: Lepr/Tomato+ osteoblasts. Arrowheads: Lepr/
Tomato+ osteocytes.
(C and D) Confocal images of bone tissues from 15-week-old Lepr-cre/Tomato mice stained with osteocalcin (green) (C) and DMP1 antibodies (green) (D).
(E) Z stack confocal images of thick bone sections in 6-week-old Col1(2.3)-Gfpmice stained with Lepr antibody (red). Right: magnified view the area of around the
cortical bone. Arrows: Col1(2.3)-GFP-positive mature osteoblasts.
(F) Z stack confocal images of thick bone sections in 15-week-old Lepr-cre/Tomato mice stained with Lepr antibody (white). Arrows: Lepr/Tomato+ osteocytes.
Arrowheads: Lepr/Tomato+ osteoblasts. Nuclei were detected by Hoechst 33342 (blue).
Scale bars represent 500 mm (E, left panel), 200 mm (B), 100 mm (A), 30 mm (E, right panels) and (F), and 10 mm (C) and (D). See also Figure S3.
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Figure 4. P5-iOsx-Derived BM Stromal Cells Contribute to Tissue Remodeling after Tissue Injury
(A–F) Z stack confocal (A andD) and confocal (B, C, E, and F) images of thick bone sections at day 6 postirradiation stainedwith BODIPY (493/503) (green) (A, B, D,
and E) or Perilipin antibody (green) (C and F) from 8-week-old Lepr-cre/Tomato mice (A–C) or P5-labeled iOsx/Tomato mice after 15 weeks chase (D–F). Arrows:
Tomato+ adipocytes.
(G–L) Images of bone sections at day 8 post-bone fracture from P5-labeled iOsx/Tomato mice after 32 weeks chase (G–I) or 15-week-old Lepr-cre/Tomato
mice (J–L). Serial sections stained with Toluidine blue (G and J). Z stack confocal (H and K) and confocal (I and L) images of thick bone sections stained with
(legend continued on next page)
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Lepr-cre with an inducible diphtheria toxin (DT) receptor (iDTR)
line and examined the effect of the depletion of Lepr+ cells on
the adipogenesis. The number of irradiation-induced adipocytes
was significantly decreased by the depletion of Lepr+ cells (Fig-
ures S4B–S4E). However, no effect was observed in the number
of adipocytes after DT injection in the control groups (Figures
S4D and S4E). These results thus suggest that irradiation-
induced adipocytes are derived from Lepr/Tomato+ BM cells
as well as P5-iOsx/Tomato+ BM stromal cells. Interestingly,
consistent with our results, a recent report has shown that the
deletion ofWnt/b-catenin-signaling (an inhibitory signal of adipo-
genesis) in Osx-expressing cells leads to increased numbers of
BM adipocytes (Song et al., 2012).
To determine whether P5-iOsx/Tomato+ and Lepr/Tomato+
BM stromal cells participate in the regenerative healing process
after bone fracture, we used the semistabilized tibia fracture
model (Maes et al., 2006) and subjected 32-week-old P5 pulsed
iOsx/Tomato and 15-week-old Lepr-cre/Tomato mice to bone
fracture. Tomato label-retaining chondrocytes were not ob-
served in P5 pulsed iOsx/Tomato mice after a chase for 3 weeks
(data not shown). Eight days after bone fracture, P5-iOsx/
Tomato+ cells were observed in the newly formed chondrogenic
area of the fracture callus (Figures 4G and 4H). Some of the P5-
iOsx/Tomato+ cells were also positive for the chondrocyte
marker Sox9 indicating that P5-iOsx/Tomato+ cells differenti-
ated into chondrocytes and contributed to the bone fracture
healing process (Figures 4G–4I). Lepr/Tomato+ cells were also
detected as Sox9-positive cells in the fractured callus in Lepr-
cre/Tomato mice (Figures 4J–4L). We confirmed that Lepr/
Tomato+ cells in the fracture callus did not express Lepr with
anti-Lepr antibody (Figure S4F), suggesting that these cells are
the progeny of Lepr+ cells.
A previous report showed that periosteal cells contribute to the
woven bone callus formation in the fractured bone healing
process (Grcevic et al., 2012). Because P5-iOsx/Tomato+ cells
and Lepr/Tomato+ cells were also observed in the periosteum
(Figures S1F and 3A), it suggests that these cells may also
contribute to the callus formation. Interestingly, P5-iOsx/
Tomato+ cells and Lepr/Tomato+ cells accumulated around
the needle inserted into the BM for the tibia stabilization after
bone fracture, suggesting that MSPC progeny also contributed
to the granulation tissue surrounding the foreign body (Fig-
ures 4H2 and 4K20) (Singer and Clark, 1999). Collectively,
these data indicate that Lepr+ P5-iOsx/Tomato+ BM stromal
cells are bona fide MSPCs, and they contribute to tissue regen-
eration as a source of osteo-, adipo-, and chondro-precursors
in vivo.
It is tempting to speculate that the hematopoietic stroma may
undergo a makeover similar to the transition of primitive to defin-
itive hematopoiesis during development (Dzierzak and Speck,
2008). Although both primitive and definitive stromal precursors
are endowed with the capacity to contribute to bone and stromal
lineages, it is possible that they play important functions in regu-Sox9 antibody (white). The numbered squares indicate the area of respective
chondrocytes. #Mark of the needle used for bone stabilization during bone fractur
Nuclei were detected by Hoechst 33342 (blue).
Scale bars represent 500 mm (G), (H), (J), and (K), 200 mm (A) and (D), 50 mm (I) a
Develating the proliferative and quiescent phases of HSCs. HSCs
indeed proliferate markedly in the BM during development and
become highly quiescent after weaning (Bowie et al., 2006).
Further studies will be needed to explore the differential proper-
ties of these stromal precursors.
EXPERIMENTAL PROCEDURES
Experimental Animals
C57BL/6, B6.129-Leprtm2(cre)Rck/J (Lepr-cre), B6.Cg-Gt(ROSA)26Sortm14
(CAG-tdTomato)Hze/J, and C57BL/6-Gt(ROSA)26 Sortm1 (HBEGF) Awai/J
mice were purchased from Jackson Laboratory. Osx-creERT2 mice (Maes
et al., 2010) were provided by H.M.K. and backcrossed with C57BL/6 for
five generations. Nes-Gfp mice (Mignone et al., 2004) were bred in our facil-
ities. Col1(2.3)-Gfp mice (Kalajzic et al., 2002) were provided from D. Rowe,
J. Butler, and S. Rafii. All mice were maintained in pathogen-free conditions,
and the Animal Care and Use Committees of Albert Einstein College of
Medicine approved all experimental procedures.
Antibodies and Reagents
The primary antibodies used were Alexa Fluor 647-anti-VE-Cadherin (BV13)
(Biolegend); APC-anti-CD31/PECAM-1 (MEC13.3), APC-eFluor 780-anti-
CD45 (30-F11), APC-eFluor 780-anti-Ter119 (Ter119), biotin-anti-PDGFRa
(APA5), biotin-anti-PDGFRb (APB5), and eFluor 660-anti-Ki-67 (SolA15) (all
from eBioscience); anti-Lepr and anti-fatty acid binding protein 4 (FABP4)
(all from R&D systems); anti-Osx (Abcam); anti-Osteocalcin (mOC1-20 and
R21C-01A) and anti-DMP-1 (all from TAKARA); anti-Perilipin (D1D8) (Cell
Signaling); and anti-Sox9 (Millipore). The secondary antibodies used were
Alexa Fluor 647 donkey anti-goat IgG, Alexa Fluor 488 donkey anti-goat IgG,
Alexa Fluor 488 donkey anti-rat IgG, and Alexa Fluor 633 goat anti-rabbit
IgG (all from Molecular probes), and Streptavidin eFluor 450 (eBioscience).
Alexa Fluor 488-anti-GFP (Molecular Probes) was used for enhancement of
the Nes-GFP signal. Nuclei were stained with Hoechst 33342 or DAPI (40,6-
diamino-2-phenylindole) (all from Sigma-Aldrich). Lipid droplets were stained
with BODIPY 493/503 (Molecular Probes).
Immunofluorescence Staining
Mice were perfused with 4% paraformaldehyde (PFA) for fixation, and bone
tissue were further fixed with 4% PFA for 30 min at 4C and incubated in
10%, 20%, and 30% sucrose each for 1 hr at 4C for cryoprotection and
embedded in 5% carboxymethyl cellulose (SECTION-LAB). Sections 10–
30 mm thick were prepared using Kawamoto’s film method (Kawamoto and
Shimizu, 2000). Images were acquired using a laser-scanning confocal micro-
scope (SP5 AOBS, Leica), Leica LAS-AF software (Leica), and image J
(Schneider et al., 2012). In the mouse fractured bone, sections were stained
with Toluidine blue (Sigma-Aldrich) and imaged by Light microscope Zeiss
Axio Observer (Zeiss) and Axiovision software (Zeiss).
Cell Sorting and Flow Cytometry
Cell sorting experiments were performed using an Aria Cell Sorter (BD Biosci-
ences). Flow cytometric analyses were carried out using an LSRII flow cytom-
eter equipped with FACS Diva 6.1 software (all BD Biosciences). Dead cells
and debris were excluded by FSC, SSC, and DAPI (Sigma-Aldrich) staining
profiles. Data were analyzed with FlowJo (Tree Star) or FACS Diva 6.1
software.
Statistics
Data were evaluated by unpaired Student’s t tests. Experiments were per-
formed three times and similar results were obtained. Statistical analyses
were performed with Graph Pad Prism 6. p < 0.05 was considered statistically
significant.zoomed right panels (H and K). Arrows: Tomato and Sox9 double-positive
e. *Fracture callus. Magnified confocal images in (H1) and (K10) panels (I and L).
nd (L), and 10 mm (B), (C), (E), and (F). See also Figure S4.
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